Insmed
INSM
#918
Rank
C$37.92 B
Marketcap
C$172.88
Share price
2.62%
Change (1 day)
-36.18%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -C$0.73 Billion

According to Insmed's latest financial reports the company's current earnings are C$1.51 Billion. In 2025 the company made an earning of -C$1.71 Billion a decrease over its 2024 earnings that were of -C$1.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.73 Billion-57.62%
2025 -C$1.71 Billion43.91%
2024 -C$1.19 Billion23.71%
2023 -C$0.96 Billion45.77%
2022 -C$0.66 Billion15.83%
2021 -C$0.57 Billion50.19%
2020 -C$0.38 Billion16.4%
2019 -C$0.33 Billion-23.9%
2018 -C$0.43 Billion59.35%
2017 -C$0.27 Billion8.52%
2016 -C$0.25 Billion47.25%
2015 -C$0.17 Billion34.53%
2014 -C$0.13 Billion58.83%
2013 -C$78.31 Million35.14%
2012 -C$57.95 Million-31.92%
2011 -C$85.13 Million854.92%
2010 -C$8.92 Million-105.22%
2009 C$0.17 B-905.06%
2008 -C$21.2 Million-27.31%
2007 -C$29.17 Million-62.41%
2006 -C$77.59 Million98.19%
2005 -C$39.15 Million0.03%
2004 -C$39.14 Million159.07%
2003 -C$15.11 Million-69.31%
2002 -C$49.22 Million
2000 -C$44.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$18.04 B-2,520.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-C$3.62 Billion 384.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$6.50 B-973.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-C$0.19 Billion-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-C$33.17 Million-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-C$73.71 Million-90.11%๐Ÿ‡บ๐Ÿ‡ธ USA